The Pharmaletter

One To Watch

mc2therapeutics_company

MC2 Therapeutics

A commercial stage biotech company focused on developing novel treatment paradigms within immune-mediated and inflammatory conditions initially focusing on manifestations in the skin.

Its approach in immunology is anchored in a deep understanding of skin biology, clinical expertise and cross-silo thinking. Fuelled by an entrepreneurial mindset and creativity, MC2 Therapeutics aims to set new standards in treatment satisfaction for people with immune-mediated and inflammatory conditions.

Want to Update your Company's Profile?


More MC2 Therapeutics news >